Disclosure-Driven Uncertainty in China's Antibody Drug Patent Examination: Enablement, Support, and a Roadmap for Foreign Applicants
Fields of Study & Subjects
Biosimilars and Bioanalytical Methods
Pharmaceutical Economics and Policy
Monoclonal and Polyclonal Antibodies Research
Publication details
- Journal / source
- SSRN Electronic Journal
- Publication date
- 1 January 2026
- Document type
- Preprint